Astra Zeneca

Case History

A key part of Astra Zeneca’s global business strategy was to reduce the time taken to bring new drugs to market.

Together with the client, we identified that an effective way to achieve this would be to speed up the central hub of ‘PARD’ (research and development) which interrelated with all other functions, such as Legal and Marketing.

Our PARD behaviour change programme helped to significantly reduce development timescales.